Premier Path Wealth Partners’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $329K | Buy |
4,210
+395
| +10% | +$30.9K | 0.05% | 312 |
|
|
2025
Q1 | $277K | Buy |
3,815
+8
| +0.2% | +$580 | 0.04% | 315 |
|
|
2024
Q4 | $282K | Sell |
3,807
-467
| -11% | -$34.6K | 0.04% | 313 |
|
|
2024
Q3 | $282K | Sell |
4,274
-1,256
| -23% | -$82.9K | 0.04% | 308 |
|
|
2024
Q2 | $511K | Buy |
5,530
+726
| +15% | +$67.1K | 0.09% | 220 |
|
|
2024
Q1 | $459K | Buy |
4,804
+1
| +0% | +$96 | 0.09% | 221 |
|
|
2023
Q4 | $366K | Buy |
+4,803
| New | +$366K | 0.08% | 225 |
|